Skip to main content
High RiskFDAfda-H-0049-2025OTHER

Sauce, Creamy Butter; packaged in clear, unlabeled bulk 6-pound bags/4 bags to a case. Lot code# 701493 stamped on bag.

Category
Units Affected
1
Recall Date
April 8, 2025
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0049-2025.

Firm's product, Creamy Butter Sauce, was manufactured with recalled ingredient (Cilantro) which contained small wood like pieces.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0049-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Goodsource Solutions, Incorporated or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0049-2025.

GoodSource Solutions, Incorporated

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Goodsource Solutions, Incorporated Recall FAQ

Goodsource Solutions, Incorporated is the subject of a dairy safety report: Sauce, Creamy Butter; packaged in clear, unlabeled bulk 6-pound bags/4 bags to a case. Lot code# 701493 stamped on bag.. The notice was published on April 8, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 1 units are potentially affected.